Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yurek Paprocki"'
Publikováno v:
Diabetes Therapy
Introduction The superior efficacy and safety of semaglutide once-weekly (QW), compared with dulaglutide, liraglutide, or exenatide QW, have been demonstrated in the SUSTAIN trials. This study assessed treatment persistence and adherence to semagluti
Autor:
Brent A. Williams, Jonathan P. Brady, Stephen Voyce, Neela Kumar, Yurek Paprocki, Jigar Rajpura
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 24(7)
To quantify changes over time in cardiovascular (CV) risk factor control and in the uptake of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors from 2007 to 2020 in a real-world community-based
Publikováno v:
ClinicoEconomics and Outcomes Research. 12:555-566
Objective Weight reduction is a key component of diabetes management in adults with type 2 diabetes mellitus (T2DM), yet the benefits of weight loss in T2DM patients have been difficult to quantify. We examined the medical literature regarding the re
Publikováno v:
Clinical therapeutics. 43(5)
Purpose Patients managing type 2 diabetes mellitus (T2DM) often require combination therapy to meet their blood glucose control targets. With limited real-world evidence focused on the use of glucagon-like peptide 1 receptor agonist (GLP-1RA) therapi
Publikováno v:
Current medical research and opinion. 34(1)
Aims: Approximately 1.25 million people in the US have type 1 diabetes mellitus (T1DM), a chronic metabolic disease that develops from the body’s inability to produce insulin, and requires life-long insulin therapy. Poor insulin adherence may cause
Publikováno v:
Current medical research and opinion. 34(1)
Aims: More than 29 million people in the US have type 2 diabetes mellitus (T2DM), a chronic metabolic disorder characterized by a progressive deterioration of glucose control, which eventually requires insulin. Abnormally low levels of blood glucose,
BACKGROUND Few studies assessing the correlation between patient-reported outcomes and patient-generated health data from wearable devices exist. OBJECTIVE The aim of this study was to determine the direction and magnitude of associations between pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85c69bb2e0ccacf24cc9678576079791
https://doi.org/10.2196/preprints.8122
https://doi.org/10.2196/preprints.8122
Publikováno v:
JMIR mHealth and uHealth
JMIR mHealth and uHealth, Vol 6, Iss 6, p e131 (2018)
JMIR mHealth and uHealth, Vol 6, Iss 6, p e131 (2018)
BackgroundFew studies assessing the correlation between patient-reported outcomes and patient-generated health data from wearable devices exist. ObjectiveThe aim of this study was to determine the direction and magnitude of associations between patie